Category: 348-67-4

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.348-67-4,H-D-Met-OH,as a common compound, the synthetic route is as follows.

Methionine (0.3 mmol,)And NaOH (0.3 mmol) were dissolved in 30 ml of a mixed solvent (VC2H5OH: VH2O = 5: 1)Stirring for 5 hours,So that it is fully dissolved; then add CuCl2 (0.3mmol),Stirring for 24 hours;Then, 3,4,7,8-tetramethyl-1,10-phenanthroline (0.3 mmol) was added,Stirring for 48 hours;Filter, take its clear liquid into 20ml of small test tube, the ether added to the filtrate above the filtrate and ether volume ratio is about 1: 2.5, standing, about a week after the blue crystal., 348-67-4

The synthetic route of 348-67-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Capital Normal University; Lu, Xiaoming; Zhang, Bo; Zhang, Weichuan; Cheng, Yifeng; Sun, Xiaojing; (60 pag.)CN105440059; (2016); A;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

348-67-4, H-D-Met-OH is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Step (1): To a 2 L four-necked flask was added 153.10 g of D-methionine, 420 g of water, 200 mL of methanol and 158.21 g of diethyl sulfate, and the mixture was stirred at room temperature, and 45 g of concentrated sulfuric acid After the end of heating to 30 ~ 40 , 10h, the recovery of methanol under reduced pressure.After the reaction with anhydrous sodium carbonate solid to adjust the pH to 8 ~ 9, continue 40 reaction 10h.After the reaction is over,The solvent was distilled off under reduced pressure.

348-67-4, 348-67-4 H-D-Met-OH 84815, acatalyst-ligand compound, is more and more widely used in various fields.

Reference£º
Patent; Anhui Zhishan New Materials Co., Ltd.; Wei Kaiju; Ren Mingxiu; Cui Yang; Chen Zhongming; Xie Yineng; (9 pag.)CN106928110; (2017); A;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI